Posts in Series 2
Canadian Emergency Ventilators project adapting 30-year-old ventilator design in battle against COVID-19

The Canadian Emergency Ventilators project involves updating 30-year-old Winnipeg Ventilator IP and design by Dr. Magdy Younes for Canada’s industrial base. 

Using an agile design strategy, the Winnipeg Ventilator IP is being adapted for Canadian manufacturing supply chains that are not normally affiliated with ventilator production. 

Initial project funding is provided by NGen as part of the COVID-19 initiative. Led by StarFish Medical, the effort includes Dr. Magdy Younes and Cerebra Health along with NGen’s manufacturing partners for components within Canada’s industrial base. Solutions are based upon available component design that will not impair supply to existing ventilator manufacturers.

See the source >>

Cambridge company building N95 mask disinfection units

PRESCIENTX, a medical device company based in Cambridge, Ontario, has begun taking orders for a newly developed device that uses ultraviolet light to rapidly disinfect masks.

The device, dubbed the Terminator CoV, is adjustable to fit masks of various sizes, and can process up to 500 masks per hour. Operators can adjust the speed of the conveyor belt that loads masks into the Terminator CoV.

See the source >>

Precision Biomonitoring receives funding to play an important role that will help increase COVID-19 testing in Canada

Precision Biomonitoring, an industry leader in point-of-need molecular detection tools, has announced that it has received approval and funding from Next Generation Manufacturing Canada (NGen) to support manufacturing needs for the production of its TripleLockTM SARS-CoV-2 Go-Strips.

The funding will enable Precision Biomonitoring to work directly with Canadian manufacturers to rapidly increase production of its SARS-CoV-2 Go-Strips, which will not only support Precision Biomonitoring, but also other Canadian biotech companies working to support the accessibility of molecular testing amidst COVID-19 and into the future.